2.99
-0.065(-2.13%)
Currency In USD
| Previous Close | 3.05 |
| Open | 2.99 |
| Day High | 3.04 |
| Day Low | 2.98 |
| 52-Week High | 6.27 |
| 52-Week Low | 2 |
| Volume | 27,570 |
| Average Volume | 732,142 |
| Market Cap | 13.65M |
| PE | -2.28 |
| EPS | -1.31 |
| Moving Average 50 Days | 2.97 |
| Moving Average 200 Days | 2.94 |
| Change | -0.07 |
If you invested $1000 in Amesite Inc. (AMST) since IPO date, it would be worth $47.65 as of October 01, 2025 at a share price of $2.985. Whereas If you bought $1000 worth of Amesite Inc. (AMST) shares 3 years ago, it would be worth $1,008.45 as of October 01, 2025 at a share price of $2.985.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden
GlobeNewswire Inc.
Sep 11, 2025 10:30 AM GMT
DETROIT, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced 63% revenue growth for its NurseMagic™ platform following the launch of its census-based Enterprise sub
Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable Market
GlobeNewswire Inc.
Jul 14, 2025 10:30 AM GMT
New Tier Adds EMR Integration, Team Reporting (IDT) and Custom Form Support — Enabling Scalable Deployment Across Entire Patient CensusDETROIT, July 14, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterpr
Amesite’s HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses
GlobeNewswire Inc.
Jun 25, 2025 8:43 PM GMT
NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native languageDETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered